The impact of short-term limited-duration policy expansion on patients and the ACA individual market
This report provides insights into the impact of short-term limited-duration (STLD) policies and other recent regulatory actions on patient spending, premiums, and enrollment in the Affordable Care Act (ACA)-compliant individual marketplace. The authors used a large administrative medical and pharmacy claims database and researched publicly available rate filing materials approved for plan year 2020 in the ACA-compliant individual marketplace. This report discusses out-of-pocket expenses for individuals in hypothetical STLD coverage who are newly diagnosed with a medical condition and the average premium impact of regulatory changes including, but not limited to, STLD policy expansion and the repeal of the individual mandate policy.
This report was commissioned by The Leukemia & Lymphoma Society.
About the Author(s)
Dane Hansen
The impact of short-term limited-duration policy expansion on patients and the ACA individual market
This report provides insights into the impact of short-term limited-duration policies and other recent regulatory actions on patient spending, premiums, and enrollment in the Affordable Care Act-compliant individual marketplace.